Effectiveness of janus kinase inhibitors compared with biologic disease modifying anti-rheumatic drugs on pain reduction in rheumatoid arthritis: Results from a nationwide Swedish cohort study.
Anna EberhardDaniela Di GiuseppeJohan AsklingStefan BergmanHannah BowerKaterina ChatzidionysiouHelena Forsblad-d'EliaAlf KastbomTor OlofssonThomas FrisellCarl TuressonPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2024)
JAKis had a slightly better effect on pain outcomes at 3 and 12 months compared with TNFis, with significantly greater differences in patients previously treated with ≥2 bDMARDs. The effect of JAKis on pain reduction was at least similar to that of non-TNFi bDMARDs.
Keyphrases
- rheumatoid arthritis
- chronic pain
- pain management
- neuropathic pain
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- systematic review
- ejection fraction
- peritoneal dialysis
- type diabetes
- interstitial lung disease
- spinal cord
- patient reported outcomes
- metabolic syndrome
- adipose tissue
- skeletal muscle
- weight loss